A detailed history of Hubbell Strickland Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hubbell Strickland Wealth Management, LLC holds 4,877 shares of ABBV stock, worth $837,527. This represents 0.46% of its overall portfolio holdings.

Number of Shares
4,877
Previous 4,869 0.16%
Holding current value
$837,527
Previous $835,000 15.33%
% of portfolio
0.46%
Previous 0.42%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $1,310 - $1,594
8 Added 0.16%
4,877 $963,000
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $4,179 - $4,880
-27 Reduced 0.55%
4,869 $835,000
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $3,196 - $3,642
20 Added 0.41%
4,896 $891,000
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $3,164 - $3,564
23 Added 0.47%
4,876 $755,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $2,805 - $3,247
21 Added 0.43%
4,853 $723,000
Q2 2023

Jul 12, 2023

BUY
$132.51 - $164.9 $13,913 - $17,314
105 Added 2.22%
4,832 $651,000
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $110,626 - $127,403
-765 Reduced 13.93%
4,727 $753,000
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $16,182 - $19,406
117 Added 2.18%
5,492 $0
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $3,623 - $4,156
27 Added 0.5%
5,375 $721,000
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $3,578 - $4,548
26 Added 0.49%
5,348 $819,000
Q1 2022

Apr 28, 2022

BUY
$131.98 - $163.75 $3,563 - $4,421
27 Added 0.51%
5,322 $863,000
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $429 - $543
4 Added 0.08%
5,295 $717,000
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $3,192 - $3,623
30 Added 0.57%
5,291 $571,000
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $3,156 - $3,516
30 Added 0.57%
5,261 $593,000
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $3,273 - $3,603
32 Added 0.62%
5,231 $566,000
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $2,495 - $3,368
31 Added 0.6%
5,199 $557,000
Q3 2020

Oct 20, 2020

BUY
$85.91 - $100.83 $4,553 - $5,343
53 Added 1.04%
5,168 $453,000
Q2 2020

Jul 13, 2020

BUY
$73.37 - $98.18 $7,483 - $10,014
102 Added 2.03%
5,115 $502,000
Q1 2020

May 22, 2020

BUY
$64.5 - $97.79 $1,677 - $2,542
26 Added 0.52%
5,013 $382,000
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $2,091 - $2,617
29 Added 0.58%
4,987 $442,000
Q3 2019

Oct 21, 2019

BUY
$62.98 - $75.72 $312,254 - $375,419
4,958 New
4,958 $375,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hubbell Strickland Wealth Management, LLC Portfolio

Follow Hubbell Strickland Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hubbell Strickland Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hubbell Strickland Wealth Management, LLC with notifications on news.